Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

HEC CJ PHARM

13.060
-0.640-4.67%
Volume:11.91M
Turnover:157.09M
Market Cap:11.49B
PE:21.81
High:13.720
Open:13.700
Low:12.900
Close:13.700
Loading ...
OverviewCompanyNewsFilings

Yichang HEC Changjiang Pharmaceutical Co. Ltd. Held Annual General Meeting

Reuters
·
29 May

Yichang Hec Changjiang Pharmaceutical Co. Ltd. Announces Internal Securities Dealings Under Takeovers Code

Reuters
·
28 May

YiChang HEC ChangJiang Pharmaceutical FY Net Income RMB 482.71 Million

THOMSON REUTERS
·
28 Mar

YiChang HEC Gains Approval to Launch Hepatitis C Drug in China

MT Newswires Live
·
28 Mar

BRIEF-Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA

Reuters
·
27 Mar

YiChang HEC ChangJiang Pharmaceutical - Encofosbuvir Tablets (0.3G) Approved for Launch by Nmpa

THOMSON REUTERS
·
27 Mar

Despite shrinking by HK$405m in the past week, YiChang HEC ChangJiang Pharmaceutical (HKG:1558) shareholders are still up 74% over 3 years

Simply Wall St.
·
03 Mar

Earnings Working Against YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Share Price

Simply Wall St.
·
24 Jan

Has YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Simply Wall St.
·
16 Dec 2024

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Mar 28, 2025 Post Market
Financial Report Announcement
Aug 30, 2024
Financial Report Announcement
Mar 28, 2024
Financial Report Announcement
Aug 31, 2023
Financial Report Announcement
Mar 24, 2023

Dividend History

Ex-DateDividend
2016-06-080.177
2017-06-080.3
2017-06-200.34
2017-10-170.4
2018-06-120.366

Valuation Analysis

22.87
Current
2.79
Sector Average
90.58%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
22.87
Maximum
78.61
+1 STD
29.72
Minimum
-59.10
-1 STD
-24.14
Average
2.79

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.